scholarly article | Q13442814 |
P50 | author | Guy M. Lenk | Q37604576 |
Stephen W Reddel | Q56440591 | ||
P2093 | author name string | Giovanni Coppola | |
Leslie G Biesecker | |||
Garth Nicholson | |||
Miriam H Meisler | |||
Cole J Ferguson | |||
Adrienne E Grant | |||
Angela Scheuerle | |||
Stuart Hoffman | |||
Ericka Simpson | |||
Sat D Batish | |||
Charles F Towne | |||
Carla Brandt | |||
Michelle Yasick | |||
Randall Blouin | |||
P2860 | cites work | Analysis of genetic inheritance in a family quartet by whole-genome sequencing | Q22065898 |
VAC14 nucleates a protein complex essential for the acute interconversion of PI3P and PI(3,5)P(2) in yeast and mouse | Q24318746 | ||
Targeted capture and massively parallel sequencing of 12 human exomes | Q24615381 | ||
A map of human genome variation from population-scale sequencing | Q24617794 | ||
ArPIKfyve regulates Sac3 protein abundance and turnover: disruption of the mechanism by Sac3I41T mutation causing Charcot-Marie-Tooth 4J disorder | Q24621406 | ||
Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. | Q24678783 | ||
Crystal structure of the yeast Sac1: implications for its phosphoinositide phosphatase function | Q27660521 | ||
A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders | Q28262802 | ||
Recurrent de novo mutations of SCN1A in severe myoclonic epilepsy of infancy | Q28295604 | ||
Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J | Q28478398 | ||
Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J | Q28511673 | ||
Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration | Q30489465 | ||
Charcot-Marie-Tooth disease subtypes and genetic testing strategies | Q34681666 | ||
TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum | Q34764702 | ||
Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. | Q34913669 | ||
Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. | Q35005794 | ||
Charcot-Marie-Tooth disease: a clinico-genetic confrontation | Q37063658 | ||
The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine | Q37363150 | ||
Abundance, distribution, and mutation rates of homopolymeric nucleotide runs in the genome of Caenorhabditis elegans | Q48188761 | ||
Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy | Q49084841 | ||
P433 | issue | Pt 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1959-1971 | |
P577 | publication date | 2011-07-01 | |
P1433 | published in | Brain | Q897386 |
P1476 | title | Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4 | |
P478 | volume | 134 |
Q47875680 | A New Mutation in FIG4 Causes a Severe Form of CMT4J Involving TRPV4 in the Pathogenic Cascade |
Q38433385 | A practical approach to the genetic neuropathies. |
Q34526188 | Activity-dependent PI(3,5)P2 synthesis controls AMPA receptor trafficking during synaptic depression. |
Q38410296 | Analysis of the human diseasome using phenotype similarity between common, genetic, and infectious diseases |
Q38115571 | Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes |
Q37218495 | Biallelic Mutations of VAC14 in Pediatric-Onset Neurological Disease |
Q91444964 | Cerebral hypomyelination associated with biallelic variants of FIG4 |
Q50320192 | Charcot Marie Tooth disease type 4J with complex central nervous system features |
Q38893801 | Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration |
Q37013034 | Congenital CNS hypomyelination in the Fig4 null mouse is rescued by neuronal expression of the PI(3,5)P(2) phosphatase Fig4. |
Q37998518 | Demyelinating prenatal and infantile developmental neuropathies |
Q38687390 | Dysregulation of ErbB Receptor Trafficking and Signaling in Demyelinating Charcot-Marie-Tooth Disease |
Q38270487 | FIG4 regulates lysosome membrane homeostasis independent of phosphatase function |
Q39041490 | FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study |
Q36592491 | Fig4 deficiency: a newly emerged lysosomal storage disorder? |
Q28477563 | Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies |
Q90124366 | Genetic modifiers and non-Mendelian aspects of CMT |
Q38787166 | Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses. |
Q24617439 | In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. |
Q85335514 | Inherited neuropathies |
Q34764035 | Loss of Fig4 in both Schwann cells and motor neurons contributes to CMT4J neuropathy |
Q36166728 | Modulation of synaptic function by VAC14, a protein that regulates the phosphoinositides PI(3,5)P₂ and PI(5)P |
Q33764669 | Mouse models of PI(3,5)P2 deficiency with impaired lysosome function. |
Q37351972 | Murine Fig4 is dispensable for muscle development but required for muscle function |
Q38007033 | Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease |
Q64082434 | Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunction |
Q27332275 | Mutations in a P-type ATPase gene cause axonal degeneration |
Q30523191 | Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration. |
Q59697627 | Novel FIG4 mutations in Yunis–Varon syndrome |
Q36957125 | PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms |
Q35923223 | Phosphoinositides and vesicular membrane traffic |
Q90049726 | Phosphoinositides: Regulators of Nervous System Function in Health and Disease |
Q52311182 | Protective Role of the Lipid Phosphatase Fig4 in the Adult Nervous System. |
Q35547893 | Reactivation of Lysosomal Ca2+ Efflux Rescues Abnormal Lysosomal Storage in FIG4-Deficient Cells |
Q37657008 | Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria |
Q89578449 | Sorting Rare ALS Genetic Variants by Targeted Re-Sequencing Panel in Italian Patients: OPTN, VCP, and SQSTM1 Variants Account for 3% of Rare Genetic Forms |
Q91781195 | The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research |
Q33649917 | The Sac domain-containing phosphoinositide phosphatases: structure, function, and disease |
Q92623510 | The expanding spectrum of neurological disorders of phosphoinositide metabolism |
Q89543124 | Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes |
Q33894031 | Whole exome sequencing identifies three recessive FIG4 mutations in an apparently dominant pedigree with Charcot-Marie-Tooth disease |
Q36817367 | Yunis-Varón syndrome is caused by mutations in FIG4, encoding a phosphoinositide phosphatase |